Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4Seroma 2Postoperative Hemorrhage 2Leiomyoma 2Hemorrhage 2Blood Loss, Surgical 2Wrist Fractures 1Thromboembolism 1Stomach Neoplasms 1Sarcoma 1Polyposis, Gastric 1Ovarian Neoplasms 1Menorrhagia 1Meningioma 1Hematoma 1Hand Injuries 1Esophageal Neoplasms 1Edema 1Dupuytren Contracture 1Duodenal Neoplasms 1Disease 1Colorectal Surgery 1Colonic Neoplasms 1

Interventions

Propofol 3Oxaliplatin 3Morphine 3Fentanyl 3Sevoflurane 2Ropivacaine 2Fluorouracil 2Capecitabine 2Bupivacaine 2Bevacizumab 2Acetaminophen 2polyethylene glycol 3350 1oxycodone-acetaminophen 1gatorade 1fish oil triglycerides 1Vitamin D 1Tranexamic Acid 1Tramadol 1Tegafur 1Sodium Chloride 1Simethicone 1Saline Solution 1Rivaroxaban 1Polyethylene Glycols 1Pirinitramide 1Panitumumab 1Orphenadrine 1Neuroleptanalgesia 1Midazolam 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Colonic Neoplasms × Tranexamic Acid × Clear all
NCT05345613 2026-01-13

Tranexamic Acid During Colonic Endoscopic Resection Procedures

Assaf-Harofeh Medical Center

Phase 4 Recruiting
200 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡